US equities
|
NVDA
$239.60
▲+2.42%
SPCX
$169.50
▲+6.63%
MU
$1,061.15
▼-1.28%
TSLA
$380.80
▲+2.76%
SNDK
$1,693.25
▼-1.55%
MSFT
$528.31
▲+2.08%
INTC
$116.37
▼-2.48%
META
$742.47
▲+1.98%
NVDA
$239.60
▲+2.42%
SPCX
$169.50
▲+6.63%
MU
$1,061.15
▼-1.28%
TSLA
$380.80
▲+2.76%
SNDK
$1,693.25
▼-1.55%
MSFT
$528.31
▲+2.08%
INTC
$116.37
▼-2.48%
META
$742.47
▲+1.98%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Relmada Therapeutics, Inc. - Common Stock
(NQ:
RLMD
)
3.495
-0.105 (-2.92%)
Delayed Quote
Updated: 3:12 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Loading chart...